Bristol Myers Squibb· @bmsnews · X·· 13 天前AI 评分42
AI 导读
#MEDIA: 今天在 #CCRWest2026 上，我们公布了一项评估某已获批药物用于活动性#银屑病关节炎（PsA）成人患者的 III 期研究的两年结果。阅读更多：https://bit.ly/4AnsaKQ
正文
#MEDIA: Today at #CCRWest2026, we announced two-year results from the Phase 3 study evaluating an approved medicine for adults with active #PsoriaticArthritis (PsA). Read more: https://bit.ly/4AnsaKQ
来源：Bristol Myers Squibb · x.com